Dermatherapy Trademark Details

Dermatherapy was registered on Tuesday, December 28, 2004 and is currently owned by Allergan, Inc. under the registration number 2915379 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 9 years ago on Wednesday, September 3, 2014, according to the United State Patent & Trademark Office
Word Mark Dermatherapy
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Allergan, Inc. of Irvine, CA

View all trademarks for Allergan, Inc.
Other Trademarks for Allergan, Inc.

Previous Owners

Skinmedica, Inc. of Carlsbad, CA

View all trademarks for Skinmedica, Inc.
Other Trademarks for Skinmedica, Inc.

Bioform Medical, Inc. of San Mateo, CA

View all trademarks for Bioform Medical, Inc.
Other Trademarks for Bioform Medical, Inc.

Cutanix Corporation of Los Altos, CA

View all trademarks for Cutanix Corporation
Other Trademarks for Cutanix Corporation
Serial Number 78215259
Registration Number 2915379
Status Date Wednesday, September 3, 2014
Filing Date Wednesday, September 3, 2014
Registration Date Tuesday, December 28, 2004

Correspondent

Michael K. Bosworth, Esq.
Burns, Doane, Swecker & Mathis, LLP
P.O. Box 1404
Alexandria VA 22313-1404

Case File Statements

Goods & Services Gels, namely, face, and body gels, creams, namely, day and night creams, neck, hand, face, body, foot, breast, massage creams, anti-wrinkle and eye cream; oil and wax removers, toners, namely, face and body toners, and hair care products, namely, shampoo

Classifications

International Class Codes
003 — Class 3 includes mainly items designed for cleaning, deodorizing, and other sanitary products made primarily for use on or for humans.
U.S. Class Codes 001, 004, 006, 050, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Wednesday, September 3, 2014
First Use Anywhere Saturday, November 15, 2003
First Use In Commerce Wednesday, November 19, 2003
Primary Code 003

You must be signed in to print.

Once signed in, look for the PDF button.